Prognostic factors and mortality in immunocompetent adult patients hospitalized with community-acquired pneumococcal pneumonia;Factores pronósticos, evolución y mortalidad en el adulto inmunocompetente hospitalizado por neumonía neumocócica adquirida en la comunidad

Revista Medica de Chile

Volumn 137, Issue 12, 2009, Pages 1545-1552

  Saldías P, Fernando ^a   Viviani G, Paola ^b   Pulgar B, Dahiana ^b   Valenzuela F, Francisco ^b   Paredes E, Sebastián ^b   Díaz P, Orlando ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Bacteremia; Bacterial; Pneumonia; Streptococcus pneumoniae

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACTEREMIA; CHILE; COMMUNICABLE DISEASE; COMPARATIVE STUDY; FEMALE; HOSPITALIZATION; HUMAN; IMMUNOCOMPETENCE; MALE; MIDDLE AGED; MORTALITY; PREDICTION AND FORECASTING; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; STREPTOCOCCUS PNEUMONIA; COMMUNITY ACQUIRED INFECTION; EPIDEMIOLOGY; PREDICTIVE VALUE; SEVERITY OF ILLNESS INDEX; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; CHILE; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HOSPITAL MORTALITY; HUMANS; IMMUNOCOMPETENCE; MALE; MIDDLE AGED; PNEUMONIA, PNEUMOCOCCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 76749093690     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. MARRIE TJ. Bacteraemic pneumococcal pneumonia: a continuously evolving disease. J Infect 1992; 24: 247-55.
2. AFESSA B, GREAVES WL, FREDERICK WR. Pneumococcal bacteremia in adults: a 14-year experience in an innercity university hospital. Clin Infect Dis 1995; 21: 345-51.
3. FINE MJ, SMITH MA, CARSON CA, MUTHA SS, SANKEY SS, WEISSFELD LA, KAPOOR WN. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA 1996; 275: 134-41.
4. BURMAN LA, NORRBY R, TROLLFORS B. Invasive pneumococcal infections: incidence, predisposing factors, and prognosis. Rev Infect Dis 1985; 7: 133-42.
5. ORTQVIST A, GREPE A, JULANDER I, KALIN M. Bacteremic pneumococcal pneumonia in Sweden: clinical course and outcome and comparison with non-bacteremic pneumococcal and mycoplasmal pneumonias. Scand J Infect Dis 1988; 20: 163-71.
6. AUSTRIAN R, GOLD J. Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann Intern Med 1964; 60: 759-76.
7. ORTQVIST A, KALIN M, JULANDER I, MUFSON MA. Deaths in bacteremic pneumococcal pneumonia. A compa-rison of two populations Huntington, West Virgi-nia, and Stockholm, Sweden. Chest 1993; 103: 710-6.
8. Gilbert K, Fine MJ.Assessing prognosis and predicting patient outcomes in community-acquired pneumonia. Semin Respir Infect 1994; 9: 140-52.
9. Mirzanejad Y, Roman S, Talbot J, Nicolle L. Pneumococcal bacteremia in two tertiary care hospitals in Winnipeg, Canada. The Pneumococcal Bacteremia Study Group. Chest 1996; 109: 173-8.
10. Plouffe JF, Breiman RF, Facklam RR. Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. Franklin County Pneumonia Study Group. JAMA 1996; 275: 194-8.
11. Díaz A, Torres C, Flores LJ, García P, Saldías F. Community acquired pneumococcal pneumonia in hospitalized adult patients. Rev Méd Chile 2003; 131: 505-14.
12. Kramer MR, Rudensky B, Hadas-Halperin I, Isacsohn M, Melzer E. Pneumococcal bacteremia no change in mortality in 30 years: analysis of 104 cases and review of the literature. Isr J Med Sci 1987; 23: 174-80.
13. Hook EW III, Horton CA, Schaberg DR. Failure of intensive care unit support to influence mortality from pneumococcal bacteremia. JAMA 1983; 249: 1055-7.
14. Pallares R, Liñares J, Vadillo M, Cabellos C, Manresa F, Viladrich PF et al. Resistance to penicillin and cephalos-porin and mortality from severe pneumococcal pneumo-nia in Barcelona, Spain. N Engl J Med 1995; 333: 474-80.
15. Hofmann J, Cetron MS, Farley MM, Baughman WS, Facklam RR, Elliot JA et al. The prevalence of drugresistant Streptococcus pneumoniae in Atlanta. N Engl J Med 1995; 333: 481-6.
16. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE et al. A prediction rule to identify lowrisk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-50.
17. Harrison BD, Farr BM, Pugh S, Selkon JB. Communityacquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognos-tic factors and outcome. Q J Med 1987; 62: 195-220.
18. Lim WS, Van Der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58: 377-82.
19. Fang GD, Fine M, Orloff J, Arisumi D, Yu VL, Kapoor W et al. New emerging etiologies for community acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore) 1990; 69: 307-16.
20. th informational supplement, appro-ved standard M 100-S14. Wayne County, NCCLS, 2004.
21. Schaaf B, Kruse J, Rupp J, Reinert RR, Droemann D, Zabel P et al. Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia. Eur Respir J 2007; 30: 517-24.
22. Burman LA, Trollfors B, Andersson B, Henrichsen J, Juto P, Kallings I et al. Diagnosis of pneumonia by cultures, bacterial and viral antigen detection tests, and serology with special reference to antibodies against pneumococcal antigens. J Infect Dis 1991; 163: 1087-93.
23. Marston BJ, Plouffe JF, File TM Jr, Hackman BA, Salstrom SJ, Lipman HB et al. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio. Arch Intern Med 1997; 157: 1709-18.
24. Watanakunakorn C, Bailey TA. Adult bacteremic pneumococcal pneumonia in a community teaching hospital, 1992-96. A detailed analysis of 108 cases. Arch Intern Med 1997; 157: 1965-71.
25. Frankel RE, Virata M, Hardalo C, Altice FL, Friedland G. Invasive pneumococcal disease: clinical features, seroty-pes, and antimicrobial resistance patterns in cases involving patients with and without human immunodeficiency virus infection. Clin Infect Dis 1996; 23: 577-84.
26. Espósito AL. Community-acquired bacteremic pneumococcal pneumonia. Effect of age on manifestations and outcome. Arch Intern Med 1984; 144: 945-8.
27. Vila-Corcoles A, Bejarano-Romero F, Salsench E, Ochoa-Gondar O, De Diego C, Gómez-Bertomeu F et al. Drug-resistance in Streptococcus pneumoniae isolates among Spanish middle aged and older adults with community-acquired pneumonia. BMC Infect Dis 2009; 9: 36.
28. Bordón J, Peyrani P, Brock GN, Blasi F, Rello J, File T, Ramírez J, Capo Study Group. The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort study. Chest 2008; 133: 618-24.
29. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44 (Suppl 2): S27-72.
30. British Thoracic Society Standards of Care Committee. British Thoracic Society Guidelines for the management of community-acquired pneumonia in adults. Thorax 2001; 56 (Suppl IV): 1-64.
31. British Thoracic Society Pneumonia Guidelines Committee. The British Thoracic Society Guidelines for the management of community-acquired pneumonia in adults - 2009 update. www.britthoracic.org.uk/guidelines.
32. Brandenburg JA, Marrie TJ, Coley CM, Singer DE, Obrosky DS, Kapoor WN et al. Clinical presentation, processes and outcomes of care for patients with pneumococcal pneumonia. J Gen Intern Med 2000; 15: 638-46.